Clinical Director, Center for Multiple Myeloma Massachusetts General Hospital Cancer Center Boston, Massachusetts
Learning Objectives:
Evaluate the current treatment landscape and clinical trial data for emerging cellular therapies for R/R MM
Identify R/R MM management strategies, incorporating novel therapeutic targets to overcome the challenges of therapeutic resistance, AEs, and tolerability